What is PABA (Para-Aminobenzoic Acid)?

PABA (para-aminobenzoic acid) is a small organic compound found naturally in foods like liver, eggs, and whole grains, and produced in small amounts by gut bacteria. It was once labeled 'Vitamin Bx' because early researchers thought it was essential, though we now know the body doesn't require it from diet in the way true vitamins do. It has a long history of use in dermatology and connective tissue health.

How does PABA (Para-Aminobenzoic Acid) work?

PABA appears to work in two main ways: topically, it absorbs UV light and protects the skin from sun damage; internally, it may help soften and break down fibrous tissue buildup by influencing the balance of proteins that regulate tissue formation. It also plays a role in supporting folic acid activity in gut bacteria and may support melanin production in hair follicles.

What forms does PABA (Para-Aminobenzoic Acid) come in?

Available as oral capsules and tablets (typically 100–500 mg), topical creams and sunscreens, and bulk powder. The prescription form Potaba (potassium para-aminobenzoate) has been used in clinical settings at much higher doses (12 g/day) for connective tissue disorders.

Where it comes from:

PABA gained popularity in the mid-20th century as one of the first chemical UVB filters used in sunscreens. It was widely used in sunscreen formulations from the 1940s through the 1980s before largely being replaced due to skin sensitivity concerns. Internally, it has been studied since the 1950s for fibrotic conditions like Peyronie's disease and scleroderma.

What does PABA (Para-Aminobenzoic Acid) help with?

• Peyronie's disease (penile fibrosis): PABA, in its prescription potassium form (Potaba), has been studied more than any other oral agent for Peyronie's disease — a condition involving fibrous plaque buildup in the penis that causes painful curvature. It appears to reduce plaque size and pain in some men, though results vary and treatment requires months of high-dose therapy.
• Scleroderma and skin hardening: Scleroderma causes the skin and connective tissues to harden and tighten. PABA has been explored as a way to soften fibrotic tissue by influencing the proteins involved in collagen overproduction. Older clinical studies showed modest improvements in skin softness with long-term high-dose use.
• Sun sensitivity and UV protection: Topically, PABA is a potent UVB absorber and was one of the first sunscreen actives ever used. Applied to the skin, it creates a chemical barrier against the UV rays most responsible for sunburn and skin damage. It has largely been replaced in modern sunscreens due to allergic reactions in some users, but it remains effective where tolerated.
• Hair pigmentation and premature graying: PABA has a longstanding folk reputation for restoring or maintaining hair color, likely because it's needed for melanin production pathways. Some older case reports and small studies noted partial hair color restoration, particularly when graying was linked to nutritional deficiency or pantothenic acid depletion. The evidence here is preliminary and mostly historical.
• Vitiligo (skin depigmentation): PABA has been explored in vitiligo — a condition where patches of skin lose their pigment — because of its potential role in melanin synthesis support. Early clinical observations were promising, but modern controlled research in this area is limited.
• Lupus-related skin symptoms: Some historical clinical use of PABA focused on inflammatory and autoimmune skin conditions including lupus erythematosus, where its anti-inflammatory and pigmentation-supporting properties were thought to be helpful. This use is based largely on older observational reports rather than modern trials.
• Skin texture and aging: Because PABA supports collagen regulation and UV protection, it has been used in anti-aging skin formulations. Regular topical use may help maintain smoother, more evenly toned skin, though it's far less common in current cosmetic products than it once was.
• Infertility related to fibrosis: There is limited older research suggesting PABA (as Potaba) may help in cases where fibrotic changes in reproductive tissue contribute to infertility, as part of its broader antifibrotic action. This is a niche and not well-studied application.

What can PABA (Para-Aminobenzoic Acid) help prevent?

• UV-induced sunburn (topical use)
• Progression of fibrotic tissue changes when used early in connective tissue disease

Which foods are rich in PABA (Para-Aminobenzoic Acid)?

1. Beef liver: One of the richest dietary sources of PABA, also supplying B vitamins that work alongside it
2. Eggs: Contain measurable PABA along with protein and folate that support similar pathways
3. Whole grains (wheat germ, bran): Whole grain products contain small amounts of PABA along with B vitamins
4. Spinach and leafy greens: Provide PABA alongside folate, which works closely with PABA in cellular metabolism
5. Molasses (blackstrap): Traditional source associated with B-vitamin and PABA content, historically linked to hair health claims

Practical Tips:

Dietary PABA levels from food are quite low compared to therapeutic supplement doses used in clinical studies. Food sources are useful for general nutritional support but cannot replicate the concentrated doses studied for conditions like Peyronie's disease or scleroderma.

What are the side effects of PABA (Para-Aminobenzoic Acid)?

• Nausea and stomach upset (more common at high doses)
• Loss of appetite
• Skin rash or allergic contact dermatitis (topical use)
• Mild liver enzyme elevation with prolonged high-dose use
• Hypoglycemia reported rarely at very high doses
• Fever (rare, with high-dose Potaba therapy)

Good to know:

PABA is generally safe at low to moderate doses (under 400 mg/day). At the very high doses used for fibrotic conditions (8–12 g/day as Potaba), side effects become more common and medical supervision is essential. Topical PABA can cause contact sensitivity in some people.

How much PABA (Para-Aminobenzoic Acid) should you take?

• Recommended daily: 100–400 mg/day for general supplementation; 8,000–12,000 mg/day (as prescription Potaba) for fibrotic conditions under medical supervision only
• Best time of day: Divided doses throughout the day are preferred to reduce stomach upset
• With or without food: Take with food to minimize nausea, especially at higher doses
• Time to effect: 4–6 weeks for general use; 3–6 months for fibrotic conditions
• How long to take it: Short-term or ongoing use is fine at low doses; high-dose Potaba therapy for fibrotic conditions should be medically supervised and typically continues for several months — do not self-medicate at those levels